WO2015084804A1 - Combination of mdm2 inhibitor and braf inhibitor and their use - Google Patents

Combination of mdm2 inhibitor and braf inhibitor and their use Download PDF

Info

Publication number
WO2015084804A1
WO2015084804A1 PCT/US2014/068091 US2014068091W WO2015084804A1 WO 2015084804 A1 WO2015084804 A1 WO 2015084804A1 US 2014068091 W US2014068091 W US 2014068091W WO 2015084804 A1 WO2015084804 A1 WO 2015084804A1
Authority
WO
WIPO (PCT)
Prior art keywords
formula
pharmaceutically acceptable
acceptable salt
cancer
according
Prior art date
Application number
PCT/US2014/068091
Other languages
French (fr)
Inventor
Erling EMERSON
Ensar HALILOVIC
Hui-qin WANG
Matthew ZUBROWSKI
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to US201361911174P priority Critical
Priority to US61/911,174 priority
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of WO2015084804A1 publication Critical patent/WO2015084804A1/en

Links